drugset / Trial / NCT00084227
Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective is to confirm the hypothesis that azithromycin plus chloroquine is non-inferior to atovaquone-proguanil for the treatment of symptomatic, uncomplicated malaria due to P. falciparum.
Timeline
- Start
- 2004-07
- Primary completion
- —
- Completion
- 2005-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atovaquone | Small molecule | — | — |
| Subject | Azithromycin | Small molecule | — | — |
| Subject | Chloroquine | Small molecule | — | — |
| Subject | Proguanil | Small molecule | — | — |